The sale of Roche's non-prescription business Roche Consumer Health (RCH) to Bayer was closed on 31 December 2004. Following approval by the European Union antitrust authorities, the necessary clearance has now also been obtained from the other relevant authorities. In a few smaller markets where the transaction has yet to be closed, completion is expected within the next few months. The total value of the transaction amounts to around 3.6 billion Swiss francs.
